Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Harvard Scientific's liposomal prostaglandin E1 begins clinical trials

July 19, 1996

Neocrin obtains exclusive rights to University of Texas patent

July 19, 1996

Pharmacia & Upjohn reveals non-enzymatic protein glycosylation inhibitors

July 19, 1996

Hemosol's hemoglobin manufacturing process covered under U.S. patent

July 19, 1996

KGF in preclinical development in Japan for mucositis

July 19, 1996

ImmuCell and Agri-Mark form joint venture for bovine lactoferrin production and commercialization

July 19, 1996

Cholesterol absorption inhibitors from Schering-Plough

July 19, 1996

Bile acid reabsorption inhibitors described by Glaxo Wellcome

July 19, 1996

Cathepsin L inhibitors described by Takeda

July 19, 1996

Vitamin D compounds with preferencial calcemic and cell differation inducing activity described

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...